MiR-181a inhibits non-small cell lung cancer cell proliferation by targeting CDK1.

about

MiR-181a inhibits non-small cell lung cancer cell proliferation by targeting CDK1.

Item

http://www.wikidata.org/entity/Q41994436

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

MiR-181a inhibits non-small cell lung cancer cell proliferation by targeting CDK1.

@en

type

Item

label

MiR-181a inhibits non-small cell lung cancer cell proliferation by targeting CDK1.

@en

prefLabel

MiR-181a inhibits non-small cell lung cancer cell proliferation by targeting CDK1.

@en

P1476

MiR-181a inhibits non-small cell lung cancer cell proliferation by targeting CDK1.

@en

P2093

Minshan Fang

http://www.w3.org/2001/XMLSchema#string

Naishu Ye

http://www.w3.org/2001/XMLSchema#string

Qiaolin Chen

http://www.w3.org/2001/XMLSchema#string

Qin Shi

http://www.w3.org/2001/XMLSchema#string

Xiuxia Zheng

http://www.w3.org/2001/XMLSchema#string

Zhan Zhou

http://www.w3.org/2001/XMLSchema#string

P2860

miR-181a induces sorafenib resistance of hepatocellular carinoma cells through downregulation of RASSF1 expression

MiR-200, a new star miRNA in human cancer

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

MicroRNAs, DNA Damage Response, and Cancer Treatment

Cancer statistics, 2009

CCL21/CCR7 promotes G2/M phase progression via the ERK pathway in human non-small cell lung cancer cells.

Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis.

Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

miR-181a-5p Inhibits Cancer Cell Migration and Angiogenesis via Downregulation of Matrix Metalloproteinase-14.

Genetic polymorphisms and microRNAs: new direction in molecular epidemiology of solid cancer.

P31

scholarly article

P356

10.3233/CBM-170350

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28946554

http://www.w3.org/2001/XMLSchema#string